MLL core components give the green light to histone methylation

Area of Science:

• Epigenetics
• Molecular Biology
• Cancer Biology

Background:

• Histone methylation, specifically trimethylation of histone H3 Lys4 (H3K4), is a key epigenetic mark associated with active gene transcription.
• Mixed-lineage leukemia 1 (MLL1) is a critical enzyme responsible for H3K4 methylation and a master regulator of developmental genes, including Hox genes.
• MLL1 alterations, such as chromosomal translocations, are implicated in the pathogenesis of acute leukemia.

Purpose of the Study:

• To elucidate the regulatory mechanism of the human MLL histone methyltransferase (MT) complex.
• To understand the role of specific components, like WDR5, in mediating H3K4 methylation.
• To investigate the conservation and functional requirement of this regulatory mechanism in gene transcription.

Main Methods:

• Structural analysis of core components of the human MLL histone methyltransferase complex.
• Biochemical assays to assess the interaction between MLL complex components and histone H3.
• Functional studies to evaluate the impact of the regulatory mechanism on H3K4 methylation and target gene expression.

Main Results:

• Core components of the human MLL MT complex form a structural platform essential for its enzymatic activity.
• WDR5 acts as a crucial mediator, facilitating the association between the histone H3K4 substrate and the MLL MT.
• This WDR5-mediated interaction is conserved from yeast to humans and is indispensable for both H3K4 methylation and the transcription of downstream target genes.

Conclusions:

• The MLL complex utilizes a conserved structural platform, with WDR5 playing a pivotal role in substrate recognition and methylation.
• This novel regulatory mechanism is fundamental for epigenetic control of gene expression and has implications for understanding MLL-related leukemogenesis.